Clinical Trial Update: Phase III Study to Evaluate the Efficacy and Safety of AGSAVI in Patients With Essential Hypertension [Phase 3]

View source ↗

Summary

A Phase III study evaluating AGSAVI for essential hypertension is in progress, with status not publicly listed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• AGSAVI

Snippet

Sponsor: Ahn-Gook Pharmaceuticals Co.,Ltd | Conditions: Hypertension | Phase 3 | Status: UNKNOWN